Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. examines how the Inflation Reduction Act could ultimately impact pharmaceutical wholesalers’ customers and business outlook.

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74

Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. Copyright © 2006-2021 Pembroke Consulting, Inc. So, you can find out what your customers, partners, and competitors are reading.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

OCTOBER 1, 2022

Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about the ConnectiveRx Enterprise Data Platform. Read on for Kylie’s insights.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceuticals Production Drugs 98

Drug Channels

MARCH 22, 2024

He then explains three ways that specialty pharmaceutical companies can use digital intake strategies to speed patient enrollment. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Adam’s insights.

Pharmaceutical Companies 98

Pharmaceutical Companies Therapies Pharmaceuticals Drugs 98

Drug Channels

JUNE 2, 2022

Bonnie describes how pharmaceutical care would benefit from standard medical record identification. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Today’s guest post comes from Bonnie Briggs, Associate Director of Clinical Effectiveness at Wolters Kluwer, Health. Read on for Bonnie’s insights.

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

OCTOBER 1, 2022

Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about the ConnectiveRx Enterprise Data Platform. Read on for Kylie’s insights.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Production Drugs 96

Drug Channels

MAY 18, 2023

To learn more about Phil’s access and commercialization solutions, download their free whitepaper, Modernize the Patient Access Experience: Transform Your Pharmaceutical Brand. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. You can also visit [link]. Read on for Patrick’s insights. d/b/a Drug Channels Institute.

Drugs 98

Drugs Pharmaceuticals 98

Drug Channels

JULY 13, 2023

Today’s guest post comes from Josh Bliss, SVP of Customer Acquisition and Head of Pharma Solutions at SingleCare Josh discusses the challenges that pharmaceutical manufacturers face connecting with consumers who could benefit from patient financial support programs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs 98

Drug Channels

APRIL 1, 2024

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy 98

Pharmacy Hospitals Pharmaceuticals Drugs 98

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Today’s guest post comes from Michael Carr, CoAssist Group Vice President at AssistRx. Read on for Michael’s insights. d/b/a Drug Channels Institute.

Specialty Pharmacies 96

Specialty Pharmacies Production Pharmacy Therapies 96

Drug Channels

APRIL 11, 2022

The content-rich agenda boasts an incredible speaking faculty joining the event, including experts from Ingenus Pharmaceuticals, McKesson, Hikma Pharmaceuticals, Cardinal Health, Teva Pharmaceuticals, Tolmar Pharmaceuticals, FFF Enterprises, IntegriChain, Mallinckrodt Pharmaceuticals, UCB Pharma, Chronicled, Fresenius-Kabi USA, Premier Inc.,

Science 97

Science Pharmaceuticals Drugs 97

Drug Channels

SEPTEMBER 9, 2021

In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. to 1:30 p.m.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs Pharmacy 98

Drug Channels

JULY 29, 2022

Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. healthcare spending. spending on healthcare.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

DECEMBER 5, 2023

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 98

Pharmacy Drugs Hospitals Pharmaceuticals 98

Drug Channels

OCTOBER 25, 2021

This post is adapted from Chapter 3 of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. The video is excerpted from my recent Drug Channels Update: Buy-and-Bill Trends video webinar. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Drugs Pharmaceuticals Hospitals 97

Drug Channels

DECEMBER 16, 2021

In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.

Pharmaceuticals 98

Pharmaceuticals Drugs Pharmacy 98

Drug Channels

AUGUST 12, 2022

Divya then explains how GoodRx partners with pharmaceutical companies to improve cost transparency and communication between patients and providers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn more about how GoodRx helps brand teams engage providers in specific specialties.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Drugs Research 96

Drug Channels

SEPTEMBER 21, 2022

FYI: The material in today’s article is adapted from Chapter 3 of our forthcoming 2022-23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to preorder at special introductory pricing. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 97

Drug Channels

OCTOBER 13, 2022

pharmaceutical distribution, payment, and reimbursement system. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. I conservatively estimate that I’ve created about 1,374,613 slides during my career. But there are two slides that people seem to appreciate the most. drug channels. Khan has other ideas about these companies.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

APRIL 21, 2022

This post is adapted from Chapter 3 of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. The video is excerpted from my recent Drug Channels Update: Buy-and-Bill Trends video webinar. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

Drug Channels

OCTOBER 2, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Click here to see the original post from May 2023. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Pharmaceuticals Marketing Drugs 97

Drug Channels

OCTOBER 4, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

FEBRUARY 1, 2022

Demonizing pharmaceuticals as a driver of U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Meanwhile, consumers shoulder a much higher portion of this spending compared with their share of hospital spending. healthcare spending growth is simply inaccurate. d/b/a Drug Channels Institute.

Hospitals 98

Hospitals Drugs Pharmaceuticals 98

Drug Channels

FEBRUARY 7, 2024

Tomorrow, we’ll be treated to a Senate show trial featuring pharmaceutical company executives. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. healthcare expenditures. Will drug pricing flat earthers (#DPFE) ever acknowledge the data?

Pharmaceutical Companies 98

Pharmaceutical Companies Drugs Pharmaceuticals Trials 98

Drug Channels

JUNE 14, 2022

The authors obscure the real story with mathematical sleight-of-hand that misrepresents the underlying data and overlooks the true nature of today’s pharmaceutical innovations. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. But as I explain, the study’s headline conclusion is highly misleading.

Drugs 98

Drugs Disease Pharmaceuticals Treatment 98

Drug Channels

OCTOBER 12, 2021

of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available at special introductory pricing until October 15. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. FYI: The material in today’s article is adapted from Section 3.1. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Hospitals Pharmaceuticals 97

Drug Channels

OCTOBER 18, 2022

As we explain below, this accelerating adoption also boosts profits for pharmaceutical wholesalers and specialty distributors—particularly when these channel participants can influence which biosimilar version a provider utilizes. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. drug distribution.

Biosimilars 97

Biosimilars Drugs Pharmaceuticals Production 97

Drug Channels

AUGUST 8, 2023

Below, I include links to publicly available comments from a diverse range of stakeholders, including 340B Health, the American Hospital Association, Biotechnology Innovation Organization, Community Oncology Alliance, National Association of Community Health Centers, and Pharmaceutical Research and Manufacturers of America.

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

APRIL 12, 2022

Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. healthcare spending growth. Will someone tell our elected officials?

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

MAY 10, 2022

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. This year’s review includes 10 companies: Eli Lilly and Company, Genentech, GlaxoSmithKline, Janssen, Merck, Novartis, Novo Nordisk, Sanofi, Takeda, and UCB. What will the DPFEs do?

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

SEPTEMBER 13, 2023

FYI: The material in today’s article is adapted from Chapter 3 of our forthcoming 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to preorder at special introductory pricing. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 97

Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. to 1:30 p.m. Click here to learn more and register.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

SEPTEMBER 17, 2024

On October 8, 2024, Drug Channels Institute will release our 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for more details. All rights reserved.

Pharmaceuticals 52

Pharmaceuticals Licensing Licensing Drugs 52

Drug Channels

DECEMBER 13, 2023

FYI: The material in today’s article is adapted from Chapter 3 of our forthcoming 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to preorder at special introductory pricing. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

APRIL 8, 2024

We intend to bring together people from the entire drug channel: pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, insurers, and plan sponsors, wholesalers and distributors, pharmacies, providers, buying groups, government officials, and more. We will also have a very limited number of sponsors.

Pharmacy 97

Pharmacy Drugs Government Pharmaceuticals 97

Drug Channels

JULY 28, 2022

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. What will the DPFEs do?

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

JUNE 13, 2023

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. This year’s review includes the following 10 companies: Eli Lilly and Company, Genentech, GlaxoSmithKline, Janssen, Merck, Novartis, Novo Nordisk, Sanofi, Takeda, and UCB.

Pharmaceuticals 98

Pharmaceuticals Drugs 98